These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22609259)

  • 1. The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men.
    Fu CP; Lee IT; Sheu WH; Lee WJ; Liang KW; Lee WL; Lin SY
    Clin Chim Acta; 2012 Oct; 413(19-20):1647-51. PubMed ID: 22609259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight loss reduces serum monocyte chemoattractant protein-1 concentrations in association with improvements in renal injury in obese men with metabolic syndrome.
    Fu CP; Sheu WH; Lee IT; Lee WJ; Wang JS; Liang KW; Lee WL; Lin SY
    Clin Chem Lab Med; 2015 Mar; 53(4):623-9. PubMed ID: 25301674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
    Kim CS; Park HS; Kawada T; Kim JH; Lim D; Hubbard NE; Kwon BS; Erickson KL; Yu R
    Int J Obes (Lond); 2006 Sep; 30(9):1347-55. PubMed ID: 16534530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
    Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
    Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome.
    Satoh-Asahara N; Suganami T; Majima T; Kotani K; Kato Y; Araki R; Koyama K; Okajima T; Tanabe M; Oishi M; Himeno A; Kono S; Sugawara A; Hattori M; Ogawa Y; Shimatsu A;
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):265-73. PubMed ID: 21051748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
    El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
    Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases].
    Hu WH; Qiao J; Li MZ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):721-4. PubMed ID: 17565837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men.
    Chew-Harris JS; Florkowski CM; George PM; Elmslie JL; Endre ZH
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):39-46. PubMed ID: 23129724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K; Matsumoto S; Aso Y; Inukai T
    J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of albuminuria with adipokines, inflammation and insulin resistance in non-diabetic subjects].
    Vasilescu R; Ionescu-Tîrgovişte C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1174-82. PubMed ID: 22276466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
    Prodjosudjadi W; Daha MR; Gerritsma JS; Florijn KW; Barendregt JN; Bruijn JA; van der Woude FJ; van Es LA
    Nephrol Dial Transplant; 1996 Jun; 11(6):1096-103. PubMed ID: 8671975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.
    Chiang WC; Lin SL; Chen YM; Wu KD; Tsai TJ
    Nephrology (Carlton); 2008 Jun; 13(3):198-203. PubMed ID: 18315702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients.
    Tretjakovs P; Jurka A; Bormane I; Mackevics V; Mikelsone I; Balode L; Reihmane D; Stukena I; Bahs G; Aivars JI; Pirags V
    Eur J Intern Med; 2009 Nov; 20(7):712-7. PubMed ID: 19818293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients.
    Lee SH; Park SA; Ko SH; Yim HW; Ahn YB; Yoon KH; Cha BY; Son HY; Kwon HS
    Metabolism; 2010 Feb; 59(2):241-6. PubMed ID: 19765773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity.
    Schernthaner GH; Kopp HP; Kriwanek S; Krzyzanowska K; Satler M; Koppensteiner R; Schernthaner G
    Obes Surg; 2006 Jun; 16(6):709-15. PubMed ID: 16756729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
    Chacón MR; Fernández-Real JM; Richart C; Megía A; Gómez JM; Miranda M; Caubet E; Pastor R; Masdevall C; Vilarrasa N; Ricard W; Vendrell J
    Obesity (Silver Spring); 2007 Mar; 15(3):664-72. PubMed ID: 17372317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects.
    Hashimoto I; Wada J; Hida A; Baba M; Miyatake N; Eguchi J; Shikata K; Makino H
    Obesity (Silver Spring); 2006 May; 14(5):799-811. PubMed ID: 16855189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
    Tam FW; Sanders JS; George A; Hammad T; Miller C; Dougan T; Cook HT; Kallenberg CG; Gaskin G; Levy JB; Pusey CD
    Nephrol Dial Transplant; 2004 Nov; 19(11):2761-8. PubMed ID: 15353578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.
    Kiani AN; Johnson K; Chen C; Diehl E; Hu H; Vasudevan G; Singh S; Magder LS; Knechtle SJ; Petri M
    J Rheumatol; 2009 Oct; 36(10):2224-30. PubMed ID: 19648301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
    Hu W; Qiao J; Yang Y; Wang L; Li R
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):53-6. PubMed ID: 21530057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.